# Study of SkQ1 as Treatment for Dry-eye Syndrome

> **NCT03764735** · PHASE3 · COMPLETED · sponsor: **Mitotech, SA** · enrollment: 452 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** Low Dose - SkQ1
- **DRUG:** High dose - SkQ1
- **DRUG:** SkQ1 (Vehicle)

## Key facts

- **NCT ID:** NCT03764735
- **Lead sponsor:** Mitotech, SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-06
- **Primary completion:** 2019-02-09
- **Final completion:** 2019-02-09
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2022-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764735, "Study of SkQ1 as Treatment for Dry-eye Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03764735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*